Development
Cullinan Therapeutics, Inc.
CGEM
$8.08
$0.141.76%
NASDAQ
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 467.07M | 466.43M | 491.80M | 390.70M | 467.29M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 13.12M | 10.28M | 6.44M | 8.33M | 7.18M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 480.19M | 476.71M | 498.24M | 399.03M | 474.47M |
|
|
|||||
| Total Current Assets | 480.19M | 476.71M | 498.24M | 399.03M | 474.47M |
| Net Property, Plant & Equipment | 3.53M | 3.99M | 4.66M | 5.06M | 5.30M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 459.00K | 459.00K | 459.00K | 459.00K | 459.00K |
| Total Assets | 484.18M | 494.71M | 521.98M | 514.99M | 561.12M |
|
|
|||||
| Total Accounts Payable | 2.49M | 951.00K | 2.49M | 2.03M | 2.66M |
| Total Accrued Expenses | 23.29M | 17.45M | 12.62M | 11.42M | 12.00M |
| Short-term Debt | -- | 1.92M | 1.89M | 1.85M | 178.00K |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.44M | 1.55M | 1.65M | 1.55M | 1.42M |
| Total Finance Division Other Current Liabilities | 914.00K | 1.58M | 1.03M | 9.32M | 6.24M |
| Total Other Current Liabilities | 914.00K | 1.58M | 1.03M | 9.32M | 6.24M |
| Total Current Liabilities | 28.14M | 23.44M | 19.68M | 26.17M | 22.50M |
|
|
|||||
| Total Current Liabilities | 28.14M | 23.44M | 19.68M | 26.17M | 22.50M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | 1.92M | 1.89M | 1.85M | 178.00K |
| Capital Leases | 2.15M | 2.45M | 2.73M | 3.17M | 3.59M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 30.29M | 25.89M | 22.41M | 29.34M | 26.09M |
|
|
|||||
| Common Stock & APIC | 654.69M | 646.92M | 639.07M | 592.55M | 585.33M |
| Retained Earnings | -200.86M | -177.05M | -137.87M | -105.66M | -47.70M |
| Treasury Stock & Other | -129.00K | -1.05M | -1.63M | -1.24M | -2.60M |
| Total Common Equity | 453.70M | 468.82M | 499.57M | 485.65M | 535.03M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 453.70M | 468.82M | 499.57M | 485.65M | 535.03M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | 192.00K | -- | -- | -- | -- |
| Total Equity | 453.90M | 468.82M | 499.57M | 485.65M | 535.03M |
|
|
|||||